Rheumatology
Conference Coverage
ACR: Filgotinib cleared phase IIb trials for rheumatoid arthritis
Key clinical point: Filgotinib appeared effective and safe as monotherapy or in combination with methotrexate in two phase IIb trials of patients...
Conference Coverage
ACR: Don’t be fooled by contaminated synovial fluid
Hold off on surgery in patients with presumed septic arthritis if they’re not otherwise too sick and their cultures don’t grow out a pathogenic...
Conference Coverage
ACR: Rheumatologists aren’t giving methotrexate a fair shot
Key clinical point: Give methotrexate a chance in rheumatoid arthritis; don’t be too quick with the biologics. Major finding: Prescribers gave up...
Conference Coverage
ACR: Years of TNF blockers did not increase risk of lymphoma in RA
Exposure to biological disease-modifying antirheumatic drugs did not increase the overall risk of lymphoma among patients with rheumatoid...
Conference Coverage
ACR: Infection risk with DMARDs doesn’t change with age of RA onset
Key clinical point: Patients with older onset RA can be safely treated with biologics. Major finding: There was no significant difference in...
News
Synovitis, effusion associated with increased pain sensitivity
News
Overweight, obese patients at greater risk for knee replacement surgery
Conference Coverage
ACR: Don’t give pneumococcal vaccine to CAPS, Behçet’s patients
Pneumococcal vaccines can trigger severe local and systemic inflammatory reactions in patients with cryopyrin-associated periodic syndromes,...
Conference Coverage
ACR: Investigational lupus drugs test new or reworked approaches to treatment
A variety of new, repurposed, and reformulated compounds have made their way into clinical trials for systemic lupus erythematosus, including a...
Conference Coverage
ACR: Criteria enable prompt diagnosis and treatment of CAPS
Conference Coverage
ACR: Adalimumab best TNFi for anterior uveitis in ankylosing spondylitis
Key clinical point: Pick adalimumab or perhaps infliximab for anterior uveitis in AS, not etanercept. Major finding: Office visits for uveitis...